Unlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutions

DUBLIN, April 1, 2024 /PRNewswire/ — The “Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition” report has been added to  ResearchAndMarkets.com’s offering.

Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. 

The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition, is a valuable resource for understanding the size and growth potential of the molecular POC market from 2023-2028. mPOC has transitioned from a novel trend to a significant contributor to the market. Instruments from companies like Abbott, BioMerieux, Cepheid, and others play a substantial role in the IVD point-of-care market. Understanding these markets is crucial for assessing the opportunity in point-of-care testing and microbiology IVD.

The report provides market sizing, forecasting, trend mapping, and competitive analysis for POC tests using PCR or other molecular technology, offering fast turnaround times and usability in near-patient settings.

This report provides real-world analysis and modeling for relevant circumstances. Analysts offer insights into near-patient molecular testing using small instruments.

The data includes the following information on systems, competitor analysis, and the size and growth of the market:

What are the mPOC market opportunities beyond COVID-19?What are the current systems on the market? Who’s winning?What’s the size of the Molecular Point-of-Care Market: 2023-2028Geographic Breakout of the Molecular Point-of-Care Market, 2023 (N. America, Europe, APAC, RoW)Segment Breakout of Molecular Point-of-Care Market, 2023 (Respiratory vs. Other)Near Patient Molecular IVD Market: 2023-2028Near Patient Molecular Market Share by Vendor, 2023Company Profiles

Competitive Analysis

Companies covered in this report, in profiles and/or product tables and market developments discussion include:

Abbott LaboratoriesAidianAkonni BiosystemsAnitoabinx healthBiocartisBioGXbioMerieuxCepheidCredo BioscienceCue HealthCuretisCuriosity Diagnostics (Bio-Rad)DiaSorinDomus DiagnosticsFluxergyGenMark DiagnosticsGenomadixGreiner Bio-OneLEX DiagnosticsMeridian BioscienceMesa BiotechMicroGEMMinute MolecularNanopathQIAGENQuantuMDx GroupQuidelRocheRover DiagnosticsSekisui DiagnosticsT2 Biosystems

Key Topics Covered:

Chapter 1: Executive Summary

Where is Molecular Point-Of-Care in 2024?Molecular Point-Of-Care Market AnalysisMarket Observations”Near-Patient” Molecular Systems MarketCurrent TrendsMolecular Point-Of-Care Diagnostics DefinedUsage of Molecular Point-Of-CareLeading MPOC PlatformsTrends

Chapter 2: Molecular Point-Of-Care Market Development and Trends

COVID-19 and Molecular POCCDC Initial Response, Long-Term SituationCOVID-19’s Unique ChallengeBarda Directs Funding to MPOCRegulatory DevelopmentsConsortia, Funding, PrizesDealsAdvantages and Disadvantages of Molecular Point-Of-CareJustification: The Sensitivity/Specificity ArgumentNew Systems and Menu ExpansionMesa Biotech Strep an ApprovalCombination Tests Changing Market: Sars-Cov-2, Flu A, Flu B, and RSVSTI Continues to be a Growth AreaDeals, Investment in MPOC SystemsRoche Acquires Lumiradx for Up to $350MThermo Acquires Mesa BiotechEU Researchers Awarded €3M to Develop POC Molecular TestsScope Fluidics AST System Sees InvestmentChina as a POC MarketCommon Tests and Analytes in POC DiagnosticsComponent Technologies of Molecular Point-Of-Care DiagnosticsMicrofluidicsqPCRMicroarraysIsothermal AmplificationTest AutomationPrimers and ProbesDetectionNext-Generation SequencingMolecular DiagnosticsReal-Time PCR (qPCR)Isothermal Amplification MethodsLine Probe AssaysNext-Generation SequencingApplications and Potential Applications for Molecular Point-Of-CareMajor Testing Applications for Molecular POC DiagnosticsInfluenzaReclassification of RIDTsHospital-Acquired Infections (HAIs)Strep ARespiratory Syncytial Virus (RSV)Emerging ApplicationsZikaOther Respiratory InfectionsGroup B StreptococcusHuman PapillomavirusHerpes Simplex VirusVaginitisTuberculosisMalariaOther Tropical and Neglected DiseasesCancerEuropean Device Regulations

Chapter 3: Market Analysis

Molecular Point-Of-Care Market Analysis”Near Patient Molecular” MarketMarket Share Near Patient

Chapter 4: Company Profiles

Abbott LaboratoriesAidianAkonni BiosystemsBinx HealthBiocartisBiomerieuxCepheidCredo Diagnostics Biomedical Pte. Ltd.Cue HealthCuretisDiasorin Genmark Diagnostics Greiner Bio-OneLucira HealthMeridian BioscienceMesa BiotechQiagenQuantumdx GroupQuidelorthoRocheSekisui DiagnosticsT2 Biosystems

For more information about this report visit https://www.researchandmarkets.com/r/o5ztpv

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/unlocking-precision-in-diagnosis-the-rise-of-molecular-point-of-care-solutions-302103787.html

SOURCE Research and Markets